Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies

Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies

US Patent 10525029 · Granted Jan 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating or preventing fibrosis in non-alcoholic fatty liver disease2025
Treatment of pyroptosis2023
Treatment of necroptosis2023
Treatment of necroptosis2023
Treatment of portal hypertension and restoration of liver function using L-ornit2022
Treatment of diseases associated with hepatic stellate cell activation using amm2021
Treatment of diseases associated with hepatic stellate cell activation using amm2021
Treatment of diseases associated with hepatic stellate cell activation using amm2021
Treatment of diseases associated with hepatic stellate cell activation using amm2021
Treatment of diseases associated with hepatic stellate cell activation using amm2021
Treatment of diseases associated with hepatic stellate cell activation using amm2021
Treating hyperammonemia, reducing plasma ammonia with TLR4 antagonists2020